179 related articles for article (PubMed ID: 35802648)
1. PIM2 Expression Induced by Proinflammatory Macrophages Suppresses Immunotherapy Efficacy in Hepatocellular Carcinoma.
Wang JC; Chen DP; Lu SX; Chen JB; Wei Y; Liu XC; Tang YH; Zhang R; Chen JC; Kan A; Xu L; Zhang YJ; Hou J; Kuang DM; Chen MS; Zhou ZG
Cancer Res; 2022 Sep; 82(18):3307-3320. PubMed ID: 35802648
[TBL] [Abstract][Full Text] [Related]
2. PIM2 promotes hepatocellular carcinoma tumorigenesis and progression through activating NF-κB signaling pathway.
Tang X; Cao T; Zhu Y; Zhang L; Chen J; Liu T; Ming X; Fang S; Yuan YF; Jiang L; Huang JD; Guan XY
Cell Death Dis; 2020 Jul; 11(7):510. PubMed ID: 32641749
[TBL] [Abstract][Full Text] [Related]
3. PIM2 Induced COX-2 and MMP-9 expression in macrophages requires PI3K and Notch1 signaling.
Bansal K; Kapoor N; Narayana Y; Puzo G; Gilleron M; Balaji KN
PLoS One; 2009; 4(3):e4911. PubMed ID: 19290049
[TBL] [Abstract][Full Text] [Related]
4. PIM2 kinase is induced by cisplatin in ovarian cancer cells and limits drug efficacy.
Musiani D; Hammond DE; Cirillo L; Erriquez J; Olivero M; Clague MJ; Di Renzo MF
J Proteome Res; 2014 Nov; 13(11):4970-82. PubMed ID: 25099161
[TBL] [Abstract][Full Text] [Related]
5. NF-kappaB- and C/EBPbeta-driven interleukin-1beta gene expression and PAK1-mediated caspase-1 activation play essential roles in interleukin-1beta release from Helicobacter pylori lipopolysaccharide-stimulated macrophages.
Basak C; Pathak SK; Bhattacharyya A; Mandal D; Pathak S; Kundu M
J Biol Chem; 2005 Feb; 280(6):4279-88. PubMed ID: 15561713
[TBL] [Abstract][Full Text] [Related]
6. Targeting monocyte-intrinsic enhancer reprogramming improves immunotherapy efficacy in hepatocellular carcinoma.
Liu M; Zhou J; Liu X; Feng Y; Yang W; Wu F; Cheung OK; Sun H; Zeng X; Tang W; Mok MTS; Wong J; Yeung PC; Lai PBS; Chen Z; Jin H; Chen J; Chan SL; Chan AWH; To KF; Sung JJY; Chen M; Cheng AS
Gut; 2020 Feb; 69(2):365-379. PubMed ID: 31076403
[TBL] [Abstract][Full Text] [Related]
7. Proviral integration site 2 is required for interleukin-6 expression induced by interleukin-1, tumour necrosis factor-α and lipopolysaccharide.
Yang J; Li X; Hanidu A; Htut TM; Sellati R; Wang L; Jiang H; Li J
Immunology; 2010 Oct; 131(2):174-82. PubMed ID: 20465571
[TBL] [Abstract][Full Text] [Related]
8. Novel inhibition of PIM2 kinase has significant anti-tumor efficacy in multiple myeloma.
Nair JR; Caserta J; Belko K; Howell T; Fetterly G; Baldino C; Lee KP
Leukemia; 2017 Aug; 31(8):1715-1726. PubMed ID: 28008178
[TBL] [Abstract][Full Text] [Related]
9. A regulatory feedback loop between HIF-1α and PIM2 in HepG2 cells.
Yu Z; Zhao X; Ge Y; Zhang T; Huang L; Zhou X; Xie L; Liu J; Huang G
PLoS One; 2014; 9(2):e88301. PubMed ID: 24505470
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of PIM2 in liver cancer decreases tumor cell proliferation in vitro and in vivo primarily through the modulation of cell cycle progression.
Kronschnabl P; Grünweller A; Hartmann RK; Aigner A; Weirauch U
Int J Oncol; 2020 Feb; 56(2):448-459. PubMed ID: 31894300
[TBL] [Abstract][Full Text] [Related]
11. Fructose-1, 6-bisphosphatase 1 interacts with NF-κB p65 to regulate breast tumorigenesis via PIM2 induced phosphorylation.
Lu C; Ren C; Yang T; Sun Y; Qiao P; Han X; Yu Z
Theranostics; 2020; 10(19):8606-8618. PubMed ID: 32754266
[No Abstract] [Full Text] [Related]
12. PIM2 deletion alleviates lipopolysaccharide (LPS)-induced respiratory distress syndrome (ARDS) by suppressing NLRP3 inflammasome.
Wang F; Xu L; Dong G; Zhu M; Liu L; Wang B
Biochem Biophys Res Commun; 2020 Dec; 533(4):1419-1426. PubMed ID: 33333710
[TBL] [Abstract][Full Text] [Related]
13. Adaptive antitumor immune response stimulated by bio-nanoparticle based vaccine and checkpoint blockade.
Bai X; Zhou Y; Yokota Y; Matsumoto Y; Zhai B; Maarouf N; Hayashi H; Carlson R; Zhang S; Sousa A; Sun B; Ghanbari H; Dong X; Wands JR
J Exp Clin Cancer Res; 2022 Apr; 41(1):132. PubMed ID: 35392977
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of Pim2-prolonged skin allograft survival through the apoptosis regulation pathway.
Liu H; Zhang C; Liang T; Song J; Hao J; Hou G
Cell Mol Immunol; 2012 Nov; 9(6):503-10. PubMed ID: 23085945
[TBL] [Abstract][Full Text] [Related]
15. Mitogen-activated protein kinases and nuclear factor-kappaB regulate Helicobacter pylori-mediated interleukin-8 release from macrophages.
Bhattacharyya A; Pathak S; Datta S; Chattopadhyay S; Basu J; Kundu M
Biochem J; 2002 Nov; 368(Pt 1):121-9. PubMed ID: 12150710
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of p38 mitogen-activated protein kinase reduces TNF-induced activation of NF-kappaB, elicits caspase activity, and enhances cytotoxicity.
Lüschen S; Scherer G; Ussat S; Ungefroren H; Adam-Klages S
Exp Cell Res; 2004 Feb; 293(2):196-206. PubMed ID: 14729457
[TBL] [Abstract][Full Text] [Related]
17. RSK2 is a new Pim2 target with pro-survival functions in FLT3-ITD-positive acute myeloid leukemia.
Hospital MA; Jacquel A; Mazed F; Saland E; Larrue C; Mondesir J; Birsen R; Green AS; Lambert M; Sujobert P; Gautier EF; Salnot V; Le Gall M; Decroocq J; Poulain L; Jacque N; Fontenay M; Kosmider O; Récher C; Auberger P; Mayeux P; Bouscary D; Sarry JE; Tamburini J
Leukemia; 2018 Mar; 32(3):597-605. PubMed ID: 28914261
[TBL] [Abstract][Full Text] [Related]
18. Strategies to Improve the Antitumor Effect of Immunotherapy for Hepatocellular Carcinoma.
Xing R; Gao J; Cui Q; Wang Q
Front Immunol; 2021; 12():783236. PubMed ID: 34899747
[TBL] [Abstract][Full Text] [Related]
19. SOCS3 expression induced by PIM2 requires PKC and PI3K signaling.
Narayana Y; Bansal K; Sinha AY; Kapoor N; Puzo G; Gilleron M; Balaji KN
Mol Immunol; 2009 Sep; 46(15):2947-54. PubMed ID: 19608279
[TBL] [Abstract][Full Text] [Related]
20. Targeting inflammatory macrophages rebuilds therapeutic efficacy of DOT1L inhibition in hepatocellular carcinoma.
Yang YB; Wu CY; Wang XY; Deng J; Cao WJ; Tang YZ; Wan CC; Chen ZT; Zhan WY; Shan H; Kuang DM; Wei Y
Mol Ther; 2023 Jan; 31(1):105-118. PubMed ID: 36183166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
